Skip to content

SBC CONSULTING

Active
Private limited companyfounded 201015 yrs activeClos du Champ de Bourgeois 6, 1330 Rixensart, BelgiumKBO/BCE: BE 0832.100.345
Summary

SBC CONSULTING has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €188,118 and a net result of €17,575. Equity is growing by ~31.4% per year across the filed fiscal years. Its solvency ranks better than 95% of 563 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

What they do
Research and development on biotechnology
NACE 72101NACE 72110
1 site
How big
€190,227total assets 2025
Equity
€188,118
Profit
€17,575
Turnover not published (abridged schema)
Financially healthy?
91 Excellent Checked score 2025
Bankruptcy chance 12 m
0.3%
Who decides
Accounts filed 12 d late0 of 4 deeds read
Why 91- Higher-failure-rate region+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Long track recordFiled after the deadlineShow the evidence

Checked score

Score 2025
Axes · tick = 2024
Profitability80▼-16
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €17,000 at 30 days acceptable
Liquidity ample (current ratio 80.71 against 8.48 in 2024; short-term debt: 1.1% and cash: 46.6% of total assets), and 1.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
98.9%
Return on assets
9.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
12 d late
2024
3 d early
2023
2 d early
2022
on the day
2021
9 d late
2020
2 d early
2019
28 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 6 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Liquidity times 10current ratio 80.71
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: Among the best 5% on solvencysector median 61.4% · 563 companies 98.9% View
  • Positive: 7 profitable years in a rowprofit 2025: €17,575 7 years View
  • Total assets 20256 fiscal years filed €190,227 View

By topic

Financials

Fiscal year
2025
Total assets
€190,227
Profit
€17,575
Solvency
98.9%
Total assets▲ 0.4%
Net result
20192025
Go to Financials

Timeline

Events
14
Since
2016
  1. 12-08-2026Annual accounts filed
  2. 31-12-2025Liquidity times 10
  3. 28-01-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
21-12-2010
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.